Trial
NCT06137651
Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Northwestern University
Collaborators
National Cancer Institute (NCI)
Condition
Breast Carcinoma
Intervention
Biospecimen Collection
Why stopped
Study terminated by the sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-01